- Assistant Professor of Neurological Surgery
- Leon Levy Research Fellow
- Feil Family Brain and Mind Research Institute
Dr. Babacar Cisse, Leon Levy Research Fellow at the Feil Family Brain and Mind Research Institute, is an award-winning neurosurgeon who performs a wide range of surgical procedures for brain and spine conditions. He has a special expertise in primary and metastatic brain and spinal tumors. He utilizes multiple modern and advanced techniques for the achievement of the safest outcomes for his patients. These techniques include neuro-navigation, ultrasound, advanced imaging, motor and speech mapping, and endoscopic and minimally invasive techniques.
Dr. Cisse is fluent in English, French, Arabic, and Wolof.
Dr. Cisse received his Bachelor’s Degree in Chemistry from Bard College. He then joined the Medical Scientist Training Program (MSTP) at the College of Physicians and Surgeons at Columbia University in New York, where he earned his medical degree and Ph.D. with Distinction. He completed his residency and chief residency in neurological surgery at NewYork-Presbyterian/Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center. He then joined the clinical faculty at the Weill Cornell Medicine Brain and Spine Center. He is also on the faculty of the Feil Family Brain and Mind Research Institute.
VIDEO Inside NYP: Chief Resident Babacar Cisse
The neurosurgery resident shares how he came to America with $26 in his pocket and achieved his dream of becoming a doctor.
WATCH VIDEO We Are Weill Cornell Medicine: Dr. Babacar Cisse
Dr. Cisse is the principle investigator of an NIH-funded basic research laboratory that studies the interactions between the immune system and brain tumors. These interactions are critical for the promotion or repression of brain tumors, their growth, and malignant transformation. The research is done using human brain tumor samples and mouse brain tumor models. The goal is to develop a thorough and basic understanding of how brain tumors develop and grow, and eventually identify therapeutic targets against which agents can be developed. His work has been published in respected peer-reviewed journals including Clinical Cancer Research, Cell, and Immunity.